Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
TA Securities kept its target price at RM1.70 per share, based on nine times its FY2026 forecast earnings per share, but upgraded the stock to a “Buy” from “Hold” after the recent dip in its share price
definitely can see the upside for Magma with this development, this strengthen the company's balance sheet and improve basic loss per share to 2.62 sen from 4.70 sen on an illustrative basis
The Malaysia Year of Medical Tourism (MYMT) 2026 is seen as a supportive catalyst for the local healthcare sector. With MYMT 2026, Malaysia is setting its sights on achieving about RM12bil in healthcare revenue by 2030. Alpha will be capitalize big on this.